SVB Wealth LLC Purchases Shares of 17,935 DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

SVB Wealth LLC acquired a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 17,935 shares of the medical instruments supplier’s stock, valued at approximately $340,000.

Several other institutional investors also recently modified their holdings of the stock. FMR LLC lifted its position in DENTSPLY SIRONA by 5.1% during the third quarter. FMR LLC now owns 9,056,774 shares of the medical instruments supplier’s stock valued at $245,076,000 after purchasing an additional 436,031 shares during the last quarter. Pacer Advisors Inc. raised its position in shares of DENTSPLY SIRONA by 15,105.1% during the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock valued at $85,478,000 after buying an additional 4,473,972 shares in the last quarter. Bank of New York Mellon Corp lifted its holdings in shares of DENTSPLY SIRONA by 27.9% during the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock worth $45,611,000 after acquiring an additional 523,692 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in DENTSPLY SIRONA by 50.4% in the third quarter. Charles Schwab Investment Management Inc. now owns 2,065,773 shares of the medical instruments supplier’s stock worth $55,900,000 after acquiring an additional 692,100 shares in the last quarter. Finally, JPMorgan Chase & Co. increased its stake in DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier’s stock valued at $49,990,000 after acquiring an additional 1,244,326 shares during the last quarter. 95.70% of the stock is currently owned by institutional investors.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ:XRAY opened at $15.59 on Wednesday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a 50-day moving average price of $18.77 and a 200-day moving average price of $21.39. The company has a market cap of $3.10 billion, a price-to-earnings ratio of -7.53, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 12 month low of $15.47 and a 12 month high of $34.28.

DENTSPLY SIRONA Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 4.11%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -14.07%.

Insider Transactions at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the purchase, the director now directly owns 81,971 shares of the company’s stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 0.52% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on XRAY shares. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. UBS Group dropped their target price on DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Leerink Partners cut shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Needham & Company LLC lowered their price objective on shares of DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating for the company in a report on Friday, February 28th. Finally, Robert W. Baird cut their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research note on Friday, February 28th. Eleven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $23.58.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.